Baker Brothers Advisors - DICERNA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$2,250,000
+10.6%
102,121
-9.7%
0.01%0.0%
Q3 2020$2,035,000
-32.9%
113,135
-5.2%
0.01%
-38.5%
Q2 2020$3,031,000
+101.4%
119,335
+45.6%
0.01%
+44.4%
Q1 2020$1,505,000–81,935–0.01%–
 Download
Other shareholders

There were no reported owners of DICERNA PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of DICERNA PHARMACEUTICALS INC shareholders